Celldex Therapeutics reported $-26784000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US USD -56715000 7.48M
Applied Genetic Technologies AGTC:US USD -18335000 26K
Aptinyx Inc APTX:US USD -15303000 2.36M
Celldex Therapeutics CLDX:US USD -26784000 546K
Immunogen IMGN:US USD -77755000 15.73M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Newlink Genetics NLNK:US USD -7251000 593K
Pfizer PFE:US USD 10.67B 3.11B
Rigel Pharmaceuticals RIGL:US USD -19037000 5.54M